KOPPERS REPORTS THIRD QUARTER 2025 RESULTS
Prnewswire· 2025-11-07 20:55
Three Months EndedSeptember 30, | (Dollars in millions, except per share | 2025 | | | | | | 2024 | | | | | | | | | Change | | | | | | | % | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | amounts) | | | | | | | | | | | | | | | | | | | | | | | Change | | | Net sales | $Â | Â | Â | Â | | 485.3 | $Â | Â | Â | Â | | | 554.3 | | $Â | Â | Â | Â | | (69.0) | | | (12.4)Â | % | | Net income attributable to Kop ...
UAE's oil trading arm plans rapid global expansion, Bloomberg reports
Reuters· 2025-11-07 20:54
公司战略与规划 - 阿布扎比国家石油公司交易部门计划在未来几年内将其处理量增加三分之二 [1] - 该交易量增长计划是公司国际扩张战略的一部分 [1] - 该信息由公司首席执行官透露 [1]
There's a reckoning happening across both bitcoin and Wall Street, says Anthony Pompliano
Youtube· 2025-11-07 20:54
here. It's been a volatile week for crypto. Joining us now, Anthony Pompiano, founder and CEO of Professional Capital Management. I I thought the whole exercise was just kind of silly to have a It's at 100,000. So, you got a price target of 1.5% million. Okay. So, that's 15 times. You're starting at 15 times as if you can make a forecast like that with any degree of of certainty or accuracy. And then your your resolution on the whole idea is so fine with because of what you're calculating. You can cut 300,0 ...
CHIPOTLE HONORS SERVICE MEMBERS WITH A VETERANS DAY ENTRÉE OFFER
Prnewswire· 2025-11-07 20:53
Accessibility StatementSkip Navigation NEWPORT BEACH, Calif., Nov. 7, 2025 /PRNewswire/ -- Chipotle Mexican Grill (NYSE: CMG) today announced that the military community can enjoy any entrée and get a second entrée for free from 4 p.m. to 8 p.m. local time on Veterans Day, Tuesday, November 11, at restaurants across the U.S. All guests with a valid military ID are eligible for the promotion.* Continue Reading On Veterans Day, guests who order an entrée in-restaurant at Chipotle and present a valid military ...
SoFi Technologies (NASDAQ: SOFI) Price Prediction and Forecast 2025-2030 (Nov 7)
247Wallst· 2025-11-07 20:50
公司增长目标 - 公司首席执行官在会议上提出成员增长目标为30% [1] - 公司同时设定收入增长目标为20% [1]
Investors Keep Faith in the AI Trade but May Need Fed Rate Cuts to Remain Steadfast
Barrons· 2025-11-07 20:47
Big tech has taken a beating this week but it's still the market's best bet. ...
India's Petronet LNG to get 500,000 T LNG from Exxon in 2026 under new deal
Reuters· 2025-11-07 20:47
供应协议 - 印度主要天然气进口商Petronet LNG将于2026年接收50万吨液化天然气 [1] - 该供应是公司与埃克森美孚之间每年120万吨供应协议的一部分 [1] - 液化天然气来自澳大利亚高更项目 [1]
GoPro targets $40M adjusted EBITDA for 2026 as innovation cycle accelerates with new product launches (NASDAQ:GPRO)
Seeking Alpha· 2025-11-07 20:46
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?
ZACKS· 2025-11-07 20:45
Atara Biotherapeutics (ATRA) shares rallied 10% in the last trading session to close at $11.82. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 32.2% loss over the past four weeks.The price rise can be attributed to growing investor optimism regarding Atara’s recent development related to its lead product candidate, tabelecleucel (tab-cel), a novel T-cell immunotherapy, which has been developed for the treatm ...
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
Newsfile· 2025-11-07 20:45
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award ProgramNovember 07, 2025 7:45 AM EST | Source: Phio Pharmaceuticals Corp.King of Prussia, Pennsylvania--(Newsfile Corp. - November 7, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio announced today that its INT ...